Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Proteome-wide drug and metabolite interaction mapping by thermal-stability profiling


Thermal stabilization of proteins after ligand binding provides an efficient means to assess the binding of small molecules to proteins. We show here that in combination with quantitative mass spectrometry, the approach allows for the systematic survey of protein engagement by cellular metabolites and drugs. We profiled the targets of the drugs methotrexate and (S)-crizotinib and the metabolite 2′3′-cGAMP in intact cells and identified the 2′3′-cGAMP cognate transmembrane receptor STING, involved in immune signaling.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Schematic representation of the thermal profiling methodology.
Figure 2: Thermal profiling results for the MTH1 inhibitor (S)-crizotinib, MTX and 2′3′-cGAMP.

Similar content being viewed by others


  1. Lee, J. & Bogyo, M. Curr. Opin. Chem. Biol. 17, 118–126 (2013).

    Article  CAS  Google Scholar 

  2. Kambe, T., Correia, B.E., Niphakis, M.J. & Cravatt, B.F. J. Am. Chem. Soc. 136, 10777–10782 (2014).

    Article  CAS  Google Scholar 

  3. Huber, K.V.M. et al. Nature 508, 222–227 (2014).

    Article  CAS  Google Scholar 

  4. Feng, Y. et al. Nat. Biotechnol. 32, 1036–1044 (2014).

    Article  CAS  Google Scholar 

  5. Lomenick, B. et al. Proc. Natl. Acad. Sci. USA 106, 21984–21989 (2009).

    Article  CAS  Google Scholar 

  6. Niesen, F.H., Berglund, H. & Vedadi, M. Nat. Protoc. 2, 2212–2221 (2007).

    Article  CAS  Google Scholar 

  7. Fedorov, O. et al. Proc. Natl. Acad. Sci. USA 104, 20523–20528 (2007).

    Article  CAS  Google Scholar 

  8. Martinez Molina, D. et al. Science 341, 84–87 (2013).

    Article  Google Scholar 

  9. Savitski, M.M. et al. Science 346, 1255784 (2014).

    Article  Google Scholar 

  10. Gad, H. et al. Nature 508, 215–221 (2014).

    Article  CAS  Google Scholar 

  11. Dayon, L. et al. Anal. Chem. 80, 2921–2931 (2008).

    Article  CAS  Google Scholar 

  12. Parlanti, E., Locatelli, G., Maga, G. & Dogliotti, E. Nucleic Acids Res. 35, 1569–1577 (2007).

    Article  CAS  Google Scholar 

  13. Allegra, C.J. et al. J. Biol. Chem. 260, 9720–9726 (1985).

    CAS  PubMed  Google Scholar 

  14. Ablasser, A. et al. Nature 498, 380–384 (2013).

    Article  CAS  Google Scholar 

  15. Cai, X., Chiu, Y.-H. & Chen, Z.J. Mol. Cell 54, 289–296 (2014).

    Article  CAS  Google Scholar 

  16. Lambert, J.-P. et al. Nat. Methods 10, 1239–1245 (2013).

    Article  CAS  Google Scholar 

  17. Yoh, S.M. et al. Cell 161, 1293–1305 (2015).

    Article  CAS  Google Scholar 

  18. Gilar, M., Olivova, P., Daly, A.E. & Gebler, J.C. J. Sep. Sci. 28, 1694–1703 (2005).

    Article  CAS  Google Scholar 

  19. Olsen, J.V. et al. Mol. Cell. Proteomics 4, 2010–2021 (2005).

    Article  CAS  Google Scholar 

  20. Perkins, D.N., Pappin, D.J.C., Creasy, D.M. & Cottrell, J.S. Electrophoresis 20, 3551–3567 (1999).

    Article  CAS  Google Scholar 

  21. Colinge, J., Masselot, A., Giron, M., Dessingy, T. & Magnin, J. Proteomics 3, 1454–1463 (2003).

    Article  CAS  Google Scholar 

  22. Burkard, T.R. et al. BMC Syst. Biol. 5, 17 (2011).

    Article  CAS  Google Scholar 

  23. Breitwieser, F.P. et al. J. Prot. Res. 10, 2758–2766 (2011).

    Article  CAS  Google Scholar 

Download references


We are grateful to W. Berger (Institute of Cancer Research, Vienna, Austria) for providing SW480 cells and P. Majek (CeMM, Vienna, Austria) for assistance with data processing. This work was supported by the Austrian Academy of Sciences, the European Union (FP7 259348, ASSET) and the Austrian Science Fund (FWF F4711, MPN).

Author information

Authors and Affiliations



K.V.M.H. designed experiments and jointly performed them with K.M.O.; A.C.M. and K.L.B. performed mass spectrometry; C.S.H.T. and J.C. performed bioinformatics analysis; and K.V.M.H. and G.S.-F. conceived the study and wrote the manuscript. All authors contributed to the discussion of results and participated in preparation of the manuscript.

Corresponding authors

Correspondence to Kilian V M Huber, Jacques Colinge or Giulio Superti-Furga.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Integrated supplementary information

Supplementary Figure 1 Data normalization.

Average thermal profiles are plotted for DMSO- and (S)-crizotinib-treated cells. Note that the two profiles (broken straight lines) are similar (no thermal shift) but imperfect. The two fitted sigmoid models are very close (dashed smooth lines), thus further indicating the absence of influence of (S)-crizotinib on the average thermal stability. Vertical arrows (only displayed for the DMSO sample for simplicity), expressed as shift in normalized coordinates, can be applied to spectra specific to a given protein for subsequent scoring of the whole dataset and can be regarded as a structural normalization considering the different protein content at each temperature.

Supplementary Figure 2 Known interactions between proteins found to be stabilized in experiments with intact SW480 cells.

Edge thickness represents interaction confidence. Data and graphical representation taken from STRING1.

Supplementary Figure 3 Original full-length anti-MTH1 western blots used for Figure 2b.

Data from SW480 intact cell experiments. (a) DMSO; (b) (S)-crizotinib. Asterisk indicates unspecific band.

Supplementary Figure 4 Melting-temperature profiles obtained for MTH1 (NUDT1) from SW480 cell lysate experiments.

Similar to intact cell experiments, treatment of SW480 cell extracts with (S)‑crizotinib leads to a stabilization of MTH1 (NUDT1). Data indicate one technical replicate.

Supplementary Figure 5 Kinases with differential melting profiles observed in cell lysates treated with 100 µM (S)-crizotinib.

Treatment of SW480 cell lysates with 100 µM (S)‑crizotinib leads to a stabilization of (a) PI3K-beta (PIK3CB) and (b) CDK2. Data indicate one technical replicate.

Supplementary Figure 6 Original full-length anti-DHFR western blots used for Figure 2d.

Data from K562 intact cell experiments. (a) DMSO; (b) methotrexate.

Supplementary Figure 7 Original full-length anti-STING western blots used for Figure 2f.

Data from RAW intact cell experiments. (a) Water; (b) 2ʹ3ʹ-cGAMP.

Supplementary Figure 8 Definition of the area score.

The area score considers a signed area between the vehicle-treated sample curve and the compound-treated curve.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–8, Supplementary Tables 1–5 and Supplementary Note 1 (PDF 2462 kb)

Source data

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huber, K., Olek, K., Müller, A. et al. Proteome-wide drug and metabolite interaction mapping by thermal-stability profiling. Nat Methods 12, 1055–1057 (2015).

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research